Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.

Caroline B K Mathiesen Michael C Carlsson Stephanie Brand Svenning Rune Möller Manja Idorn Per Thor Straten Anders E Pedersen Sally Dabelsteen Adnan Halim Peter Adler Würtzen Jens Brimnes Henrik Ipsen Bent L Petersen Hans H Wandall

J Allergy Clin Immunol

Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address:

Published: December 2018

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaci.2018.07.030	DOI Listing

Publication Analysis

Top Keywords

genetically engineered

engineered cell

cell factories

factories produce

produce glycoengineered

glycoengineered vaccines

vaccines target

target antigen-presenting

antigen-presenting cells

cells reduce

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!